Bernstein reiterates Outperform on Sun Pharma; ₹2,235 target
Bernstein retained its 'Outperform' recommendation on Sun Pharmaceutical Industries Ltd. and set a price target of ₹2,235 per share, citing expectations around dividends and buybacks between FY27-29.